Haematological Malignancies
Myeloproliferative Neoplasms – Classification, Diagnostic and Therapeutic Options in the Light of Molecular Findings
Andrzej Hellmann, Maria Bieniaszewska
The term myeloproliferative disorders (MPDs) was introduced by Demeshek in 1951.1 He postulated that various clinical conditions, such as chronic granulocytic leukaemia, polycythaemia vera (PV), idiopathic myeloid metaplasia, thrombocythaemia, megacariocytic leukaemia and erythroleukaemia, can be regarded as variable manifestations of proliferative activity of bone marrow cells. In the following few years, the term MPD was […]